Biogen, together with Invitae, is offering no-charge genetic testing to patients suspected of having or clinically diagnosed with SMA. The SMA Identified Program facilitates access to genetic testing, including SMN1 deletion/mutation and SMN2 copy number, to help accelerate or confirm the diagnosis of SMA.1
This program is available to all individuals within the United States.* The genetic test may be helpful to your patients if they are:
Specimen samples for this program are accepted from the United States only. It is a requirement for a qualified, US-based healthcare professional to submit the request.
*Inclusive of the US and Puerto Rico.